2019 ±¹¸³Áß¾ÓÀÇ·á¿ø »êºÎÀΰú ½ÉÆ÷Áö¾ö : 2019-11-17±³À°ÀÏÀÚ : 2019-11-17
±³À°Àå¼Ò : ±¹¸³Áß¾ÓÀÇ·á¿ø ¿¬±¸µ¿ 9Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2019 ±¹¸³Áß¾ÓÀÇ·á¿ø »êºÎÀΰú ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ±¹¸³Áß¾ÓÀÇ·á¿ø(¸íĪº¯°æ ±¹¸³ÀÇ·á¿ø 2010. 4)
´ã´çÀÚ : ¹ÚÁö¿µ
¿¬¶ôó : 02-2000-4737
À̸ÞÀÏ :
kmr4737@naver.com ±³À°Á¾·ù : »êºÎÀΰú, ¿µ»óÀÇÇаúÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ±âŸ
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-17 ´ë°´ç 09:10~09:30 Teratogen Counseling ÇÑÁ¤¿(±¹¸³Áß¾ÓÀÇ·á¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 09:30~09:50 Teratogenic Infections Á¶±ÝÁØ(°í·Á´ëÇб³ ¾È¾Ïº´¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 09:50~10:25 Ultrasonography for fetus exposed to teratogen Á¶Á¤¿¬(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 10:25~10:50 Screening & Diagnosis of Fetal Chromosomal abnormality ±è¹ÎÇü(°¼¹ÌÁî¸Þµðº´¿ø)
ÈÞ½Ä 11-17 ´ë°´ç 10:50~11:10 ÈÞ½Ä ()
±³À°½Ã°£ 11-17 ´ë°´ç 11:10~11:35 Àå¾Ö¿©¼ºÀÇ ÀӽŠ¹éÀ¯Áø(±¹¸³ÀçÈ°¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 11:35~12:00 Àå¾ÖÄ£È »êºÎÀΰú Áö¿ø»ç¾÷ ¿¬±¸ ÁÖ¼ºÈ«(±¹¸³Áß¾ÓÀÇ·á¿ø)
½Ä»ç 11-17 ´ë°´ç 12:00~13:20 ½Ä»ç ()
±³À°½Ã°£ 11-17 ´ë°´ç 13:20~13:40 Introduction: Korea Counseling Center for Fertility & Depression Ã־ȳª(±¹¸³Áß¾ÓÀÇ·á¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 13:40~14:00 Early Detection & Intervention of Depression during Pregnancy À̽ÂÀç(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-17 ´ë°´ç 14:00~14:20 Interpersonal Psychotherapy: Depression Following Fetal Loss ±èÀå·¡(±¹¸³Áß¾ÓÀÇ·á¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 14:20~14:40 Counseling Tailored to Infertility Treatment Stages Á¶¼Àº(°¡Ãµ´ë±æº´¿ø)
ÈÞ½Ä 11-17 ´ë°´ç 14:40~14:50 ÈÞ½Ä ()
±³À°½Ã°£ 11-17 ´ë°´ç 14:50~15:10 MotherSafe Center 10Years : Outcome & Future Perspective ±èÁÖÈñ(Çѱ¹¸¶´õ¼¼ÀÌÇÁÀü¹®»ó´ã¼¾ÅÍ)
±³À°½Ã°£ 11-17 ´ë°´ç 15:10~15:30 Teratogenicity of Contraceptive methods È«´Þ¼ö(´ëÀü¹ÌÁî¿©¼ºº´¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 15:30~15:50 Pregnancy Prevention Program of Major Teratogenic Drugs in Korea À̼ҿµ(ºÎ»êÀϽű⵶º´¿ø)
±³À°½Ã°£ 11-17 ´ë°´ç 15:50~16:10 Community Preconception Care ¼ÕÀμ÷(°Ç±¹´ëÇб³º´¿ø)
Åä·Ð 11-17 ´ë°´ç 16:10~16:20 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)